Analysts' Opinions Are Mixed on These Healthcare Stocks: Outset Medical (OM), Arvinas Holding Company (ARVN) and Innovent Biologics (OtherIVBXF)
Outset Medical to Present at the 2024 Stifel Healthcare Conference
Outset Medical (OM) Slipped on Earnings Miss and Reduced Guidance
Outset Medical Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Outset Medical Shares Are Trading Higher After the Company Reported Better-than-expected Q3 Financial Results and Raised Its FY24 Sales Guidance.
Express News | Outset Medical Shares Are Trading Higher After the Company Reported Better-than-expected Q3 Financial Results and Raised Its FY24 Sales Guidance
Outset Medical | 10-Q: Q3 2024 Earnings Report
Stifel Maintains Outset Medical(OM.US) With Buy Rating, Maintains Target Price $6
Analysts Are Bullish on Top Healthcare Stocks: AnaptysBio (ANAB), Outset Medical (OM)
Outset Medical Inc. (OM) Q3 2024 Earnings Call Transcript Summary
Outset Medical Inc. (OM) Q3 2024 Earnings Call Transcript
TD Cowen Maintains Outset Medical(OM.US) With Buy Rating, Maintains Target Price $3
RBC Capital Maintains Outset Medical(OM.US) With Hold Rating, Maintains Target Price $3
BTIG Maintains Outset Medical(OM.US) With Buy Rating, Maintains Target Price $4
TD Cowen Maintains Outset Medical(OM.US) With Buy Rating, Cuts Target Price to $3
Outset Medical's Strong Q3 Performance and Strategic Expansion Justifies Buy Rating
Express News | Outset Medical Inc: Increased 2024 Revenue Guidance to Approximately $112 Mln
Outset Medical Non-GAAP EPS of -$0.39 Beats by $0.03, Revenue of $28.7M Beats by $1.8M
Earnings Flash (OM) OUTSET MEDICAL Posts Q3 Revenue $28.7M
Earnings Flash (OM) OUTSET MEDICAL Reports Q3 Loss $-0.39